Keimyung Med J.  2018 Dec;37(2):92-96. 10.0000/kmj.2018.37.2.92.

Anesthetic and Perioperative Management of Patient with Paroxysmal Nocturnal Hemoglobinuria

Affiliations
  • 1Department of Anesthesiology and Pain Medicine, Yeungnam University College of Medicine, Daegu, Korea.
  • 2Department of Anesthesiology and Pain Medicine, Keimyung University School of Medicine, Daegu, Korea. Parkkibum@dsmc.or.kr

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare clonal hematopoietic stem cell disorder. Surgery, anesthesia, infection, trauma, and pregnancy can exacerbate hemolysis and thrombotic risk by increasing complement activity. However, perioperative treatment of eculizumab can reduce risk of hemolytic event by surgical stress. Here, we present the perioperative clinical course and adequate anesthetic management of PNH complicated by spine surgery under general anesthesia. We also describe a possible role of eculizumab for PNH patients with anticipated high risks.

Keyword

Hemoglobinuria; Hemolysis; Paroxysmal; Thrombosis

MeSH Terms

Anesthesia
Anesthesia, General
Complement System Proteins
Hematopoietic Stem Cells
Hemoglobinuria
Hemoglobinuria, Paroxysmal*
Hemolysis
Humans
Pregnancy
Spine
Thrombosis
Complement System Proteins
Full Text Links
  • KMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr